Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and AI-Driven Digital Pathology for AS Management. View press release here.
Each step. Every patient. Exactly what you need.
Schedule a meeting with us
We’re excited to connect with you while in Tampa, Florida! Visit us at Booth 317 to learn how the MyRisk® Hereditary Cancer Test has expanded and now includes all 24 colorectal cancer genes cited in national oncology guidelines.
ASCRS 2026
Location: Tampa Convention Center
When: 5/9 – 5/12
Booth: #317
Join us for our Lunch Symposium and discover how routine preoperative hereditary cancer genetic testing with the MyRisk Test can sharpen surgical planning and elevate long-term patient management in colorectal cancer.
Unrecognized Risk: How Hereditary Cancer Genetic Testing Can Transform Surgical Planning and Long‑Term Management.
Date and Time: Monday, May 11 | 12:05 PM – 1:10 PM EST
Lunch and beverages will be provided
Seats are limited
Request more information about how Myriad’s Oncology solutions can benefit you/your patients.
By submitting this form, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may unsubscribe from these communications by following the unsubscribe link or the instructions provided in the communication we send. The information you submit is governed by our Privacy Notice and our website Terms of Use.
Contact Information